Our facility takes part in numerous trials among which the long term open label extension studies are of key importance as they provide Patients with the latest medications, including biologics which are being used around the world with great success (inaccessible in Poland as of yet) in the treatment of chronic skin disorders, mainly the atopic dermatitis, or psoriasis in adults and children.
The treatment usually lasts until the moment the drugs are available in Poland. The studies are conducted in cooperation with prominent medical companies in the USA and Europe.
We also often opt for phase II studies which are more demanding but deliver more satisfaction as it is possible to discover more of the undiscovered.
Participation in clinical studies is always free of charge for the patients, insurance coverage is always granted, while travel costs are reimbursed, as a rule.
Participation in clinical studies has always been voluntary and has always required a signed informed consent form.

To date, we have been conducting various studies, among which of prominent significance are the studies dedicated to a group of patients suffering from:
· Atopic dermatitis - in children older than 6, teenagers, and adults.
· Psoriasis - in children from the age of 12), adults
· Contact eczema
· Chronic venous insufficiency, with concomitant ulceration in patients with diabetes, and without DM.
· Some variants of onychomycosis.